Sign in

CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202726770
Phone
862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Director bought 9,200 shares at $3.41 ($31,350)
  6. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $3.15 ($31,499)
  7. 4 Open-market buy President and CEO bought 15,000 shares at $3.14 ($47,100)
  8. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.54 ($17,700)
  9. 4 Open-market buy President and CEO bought 20,000 shares at $3.54 ($70,790)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 5,188 shares (to pay taxes)
  13. 4 Shares withheld for taxes Director gave up 11,632 shares (to pay taxes)
  14. 4 Grant or award Chief Business Officer acquired 4,571 shares (grant or award)
  15. 4 Shares withheld for taxes Chief Business Officer gave up 4,229 shares (to pay taxes)
  16. 4 Shares withheld for taxes Director gave up 17,898 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,748 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Business Officer gave up 3,855 shares (to pay taxes)
  19. 4 Shares withheld for taxes Director gave up 17,984 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,373 shares (to pay taxes)

Page 2 of 34 · 674 filings